← Open Payments lookup

MATTHEW KALONICK: Open Payments

NPI 1093586059 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$382 in 19 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $382

Food & beverage: $382
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$76
Amgen Inc.4$66
Merck Sharp & Dohme LLC3$46
Alnylam Pharmaceuticals Inc.2$34
AstraZeneca Pharmaceuticals LP2$33
Philips North America LLC1$33
LeMaitre Vascular, Inc.1$33
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
Novo Nordisk Inc1$16
Bayer Healthcare Pharmaceuticals Inc.1$15

Products named: CAMZYOS, REPATHA, VERQUVO, AMVUTTRA, WAINUA, Ambulatory Monitoring & Diagnostics Undivided, HYDRO LEMAITRE VALVULOTOME, JARDIANCE.

Industry payments across ND — which companies pay providers there.